CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-15 | Grant Sean Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2023-02-15 | Lin Celia Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-02-15 | Fordyce Marshall President and CEO | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 | ||
| 2023-02-13 | SEIDENBERG BETH C Director | Purchase | +10,072 | $7.20 | $72K | 1,664,702 |
| 2023-02-09 | SEIDENBERG BETH C Director | Purchase | +400 | $7.25 | $3K | 1,654,630 |
| 2023-02-08 | SEIDENBERG BETH C Director | Purchase | +45,357 | $7.22 | $327K | 1,654,230 |
| 2023-02-07 | SEIDENBERG BETH C Director | Purchase | +87,956 | $7.08 | $623K | 1,608,873 |
| 2023-02-06 | Young Joseph R SVP, Finance, Chief Acct Offcr | Purchase | +5,714 | $7.00 | $40K | 22,679 |
| 2023-02-06 | Grant Sean Chief Financial Officer | Purchase | +14,285 | $7.00 | $100K | 49,933 |
| 2023-02-06 | SEIDENBERG BETH C Director | Purchase | +131,602 | $7.03 | $925K | 1,520,917 |
| 2023-02-06 | Sofinnova Venture Partners X, L.P. 10% owner | Purchase | +285,714 | $7.00 | $2.0M | 3,467,156 |
| 2023-02-06 | Longitude Capital Partners IV, LLC 10% owner | Purchase | +1,714,285 | $7.00 | $12.0M | 1,714,285 |
| 2023-02-06 | ENRIGHT PATRICK G Director | Purchase | +1,714,285 | $7.00 | $12.0M | 1,714,285 |
| 2023-02-03 | SEIDENBERG BETH C Director | Purchase | +46,163 | $7.24 | $334K | 1,389,315 |
| 2022-12-16 | Curley Joanne Chief Development Officer | Option exercise | +1,429 | $2.90 | $4K | 28,250 |
| 2022-12-16 | Curley Joanne Chief Development Officer | Sale | −1,429 | $19.12 | $27K | 26,821 |
| 2022-12-16 | Curley Joanne Chief Development Officer | Option exercise | +783 | $2.90 | $2K | 27,604 |
| 2022-12-16 | Curley Joanne Chief Development Officer | Sale | −783 | $20.17 | $16K | 26,821 |
| 2022-12-16 | Curley Joanne Chief Development Officer | Option exercise · Stock Option (right to buy) | −2,212 | 35,801 | ||
| 2022-12-13 | Curley Joanne Chief Development Officer | Option exercise | +11,733 | $11.00 | $129K | 38,554 |
Page 18 of 30 · 581 trades